Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Jun 10 · inside the Ichimoku cloud · RSI 100 (overbought) · MACD below its signal · at its 52-week high
None of the 29 investors followed here reported a position in KALY in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a KALY trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for KALY.
No analyst coverage for this instrument.
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based in Dallas, Texas.
No recent headlines.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | +100.0% | ||
| 2025 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −50.0% |
| 2024 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2023 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2022 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2021 | 87.5 | 26.7 | 5.3 | -20.0 | -37.5 | -50.0 | -40.0 | 0.0 | -66.7 | 0.0 | 0.0 | 0.0 | −87.5% |
| 2020 | 0.0 | -42.9 | -25.0 | 0.0 | 25.0 | 13.3 | 0.0 | -11.8 | -26.7 | -9.1 | 0.0 | -20.0 | −71.4% |
| 2019 | -48.0 | 1.8 | 0.0 | 11.6 | -17.4 | -1.9 | -24.0 | 30.4 | -20.4 | -22.0 | -51.6 | -9.7 | −87.1% |
| 2018 | 25.0 | 0.0 | -40.0 | 66.7 | 20.0 | 50.0 | -55.6 | -25.0 | 0.0 | 2100.0 | -40.9 | 456.7 | +5327.5% |
| 2017 | -14.2 | -22.3 | -81.9 | -31.0 | -10.0 | -44.4 | 20.0 | -33.3 | -25.0 | 0.0 | 0.0 | 33.3 | −96.7% |
| 2016 | 0.0 | -60.0 | 1.3 | -1.2 | 0.0 | -25.0 | 48.3 | -43.8 | 20.0 | -45.8 | 53.8 | -76.0 | −94.0% |
| 2015 | 0.0 | -8.0 | 13.0 | 3.8 | 0.0 | 29.6 | -8.6 | -43.7 | 38.9 | 0.0 | 0.0 | -20.0 | −20.0% |
| 2014 | -6.7 | 0.0 | 0.0 | -19.3 | -2.7 | -5.1 | -38.7 | -15.6 | 103.7 | -52.4 | -4.6 | 0.0 | −66.7% |
| 2013 | 7.8 | -17.0 | 19.0 | 7.9 | -5.9 | -6.3 | -9.3 | -73.2 | 9.9 | -30.0 | 27.1 | -15.7 | −79.7% |
| 2012 | -24.5 | -12.0 | 2.7 | -6.7 | -1.4 | -12.8 | -25.2 | 28.9 | -4.6 | -21.1 | -23.7 | -26.0 | −77.6% |
| 2011 | -13.5 | -12.7 | 19.2 | -16.7 | 26.7 | -10.5 | -5.3 | -13.0 | -12.9 | 39.3 | 5.9 | 22.2 | +10.0% |
| 2010 | 0.2 | 27.2 | 27.5 | -7.7 | -11.7 | -19.2 | -7.7 | -5.1 | -9.3 | -14.1 | -21.2 | -13.0 | −50.0% |
| 2009 | -80.0 | -69.0 | 303.2 | 0.0 | 0.0 | 100.0 | -58.0 | 185.7 | 83.3 | 0.0 | -27.3 | 0.0 | −20.0% |
| 2008 | 23.3 | -73.0 | 0.0 | 50.0 | -13.3 | 0.0 | -11.5 | -56.5 | −83.3% |